August 2, 2023 Experience Allurion Technologies merger with Compute Health Acquisition We advised the capital markets adviser on the de-SPAC transaction
July 28, 2023 Experience Immedica Pharma acquisition of pegzilarginase assets from Aeglea We advised Immedica on the transaction
June 28, 2023 Experience Centogene strategic collaboration with Lifera We are advising Centogene on its joint venture with and convertible debt investment by Lifera
May 17, 2023 Experience Forbion European Acquisition combination with enGene We are advising Forbion European Acquisition on its de-SPAC transaction
May 12, 2023 Experience GSK exclusive licensing agreement with Scynexis We advised GSK on the transaction
May 3, 2023 Experience Invacare chapter 11 plan confirmed We advised the prepetition term loan agent and escrow agent on the transaction
March 7, 2023 Experience Atairos acquisition of LifeLabs Learning We are advising Atairos on the transaction
March 3, 2023 Experience European Biotech Acquisition $220 million combination with Oculis We advised European Biotech Acquisition on its de-SPAC transaction
January 19, 2023 Experience Sun Pharmaceutical acquisition of Concert Pharmaceuticals We advised Sun Pharmaceutical on the transaction
December 14, 2022 Experience Priveterra Acquisition initial business combination with AEON Biopharma We are advising Priveterra on the transaction